SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-000539
Filing Date
2019-01-04
Accepted
2019-01-04 07:39:53
Documents
4
Period of Report
2019-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv510358_8k.htm 8-K 51152
2 EXHIBIT 2.1 tv510358_ex2-1.htm EX-2.1 774835
3 EXHIBIT 10.1 tv510358_ex10-1.htm EX-10.1 357172
4 EXHIBIT 10.2 tv510358_ex10-2.htm EX-10.2 89817
  Complete submission text file 0001144204-19-000539.txt   1274211
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 19508398
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1